MENACTRA

Indications

• Prevention of diphtheria through vaccination
• Treatment of diphtheria infection
• Management of respiratory obstruction due to pseudomembrane

Dosage

Children: Refer to specific

Adults: Refer to specific guidelines for the treatment of diphtheria. Antitoxin and antibiotics are typically used in treatment.

Mechanism of action

The pathogenicity of Corynebacterium diphtheriae is largely due to its production of diphtheria toxin, an A-B toxin that inhibits protein synthesis in host cells. The toxin is composed of two subunits: the A subunit, which enters the cytoplasm of the cell and catalyzes the ADP-ribosylation of elongation factor 2 (EF-2), leading to cell death, and the B subunit, which binds to the cell surface receptor, facilitating the entry of the A subunit. This results in local tissue damage and systemic effects, including myocarditis and neuropathy.

Pharmacodynamics

Diphtheria toxin exerts its effects primarily through inhibiting protein synthesis, causing cell death in susceptible tissues. The resulting necrosis can lead to the characteristic pseudomembrane formation in the throat and can affect other organs, including the heart and nervous system. The immune response to the toxin and the bacteria provides some level of protection, which is the basis for vaccination strategies.

Pharmacokinetics

The pharmacokinetics of the diphtheria toxin itself are not typically described in terms of absorption, distribution, metabolism, and excretion, as it is a potent toxin rather than a conventional drug. However, the body’s immune response to the toxin is crucial for recovery. After vaccination, the body generates antibodies against the toxin, which can neutralize its effects upon exposure to the bacterium.

Pregnancy

Diphtheria vaccination is recommended during pregnancy to protect the mother and fetus. The vaccine is inactivated and poses no risk.

Breast-feeding

Diphtheria vaccination is safe during breastfeeding. Antibodies may be transferred to the infant through breast milk.

Storage

Store in a refrigerator at 2-8 degrees Celsius. Do not freeze.

Formulations

• Diphtheria toxoid vaccine

Indications

• Clinical term 1
• Common term 1
• Clinical term 2
• Common term 2

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing guidelines.

Adults: Refer to the BNF for specific adult dosing guidelines.

Mechanism of action

Dose acts by modulating the activity of specific neurotransmitter receptors and ion channels, influencing various physiological pathways. Its precise mechanism may involve interactions with G-protein coupled receptors, leading to downstream signaling effects that impact cellular responses.

Pharmacodynamics

Dose exhibits a range of effects depending on the dosage and target tissues. It is known to alter neurotransmitter release, affect ion conductance, and influence metabolic pathways, thereby contributing to its therapeutic efficacy and potential side effects.

Pharmacokinetics

Dose is generally absorbed following administration, with peak plasma concentrations occurring within a specified timeframe. Its distribution is influenced by tissue binding and permeability across cell membranes. The drug is metabolized primarily in the liver, with metabolites being excreted via renal and biliary routes. The half-life can vary based on individual patient factors, including age, liver function, and other concurrent medications.

Dosage

Children: Refer to specific drug monographs for detailed paediatric dosage information, as this will also vary widely among drugs within any given group.

Adults: Refer to specific drug monographs for detailed dosage information, as this will vary widely among drugs within any given group.

Mechanism of action

The mechanism of action for drugs within a group can vary. For example, antihypertensive drugs may work by relaxing blood vessels, reducing heart rate, or decreasing blood volume. Analgesics can work by inhibiting pain pathways in the central nervous system or blocking the production of pain-inducing chemicals. Each individual drug within a group will have its specific pathway and target molecules, such as receptors or enzymes, which are involved in its therapeutic effects.

Pharmacodynamics

Pharmacodynamics describes how a drug affects the body. Within any given drug group, the pharmacodynamics can include the drug's affinity for its target receptors, the efficacy in producing a biological response, and the onset and duration of action. For instance, some analgesics may produce rapid relief of pain, while others may have delayed effects. The dose-response relationship, which indicates how the effects of a drug change with varying doses, is also a crucial aspect of pharmacodynamics.

Pharmacokinetics

Pharmacokinetics encompasses the absorption, distribution, metabolism, and excretion (ADME) of a drug. For drugs within a group, pharmacokinetic parameters can differ significantly. Factors such as bioavailability, half-life, volume of distribution, and clearance rates are important for determining dosing regimens and understanding how long a drug will exert its effects in the body. For example, some antibiotics may be rapidly absorbed and cleared, necessitating more frequent dosing, while others may have extended half-lives allowing for less frequent administration.

Pregnancy

The safety of this drug during pregnancy has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether this drug is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Prevention of meningococcal meningitis
• Prevention of meningococcal septicemia
• Vaccination in outbreak settings
• Vaccination for travelers to endemic areas

Dosage

Children: Refer to specific vaccine guidelines for paediatric dosing.

Adults: Refer to specific vaccine guidelines for adult dosing.

Mechanism of action

Meningococcal vaccines work by introducing components of the Neisseria meningitidis bacteria, such as polysaccharide capsules or proteins, into the body. This exposure prompts the immune system to recognize and remember the bacteria, enabling a rapid and effective immune response upon future exposure.

Pharmacodynamics

The pharmacodynamic effect of meningococcal vaccines is the induction of immunological memory, resulting in the production of specific antibodies against the serogroups of Neisseria meningitidis included in the vaccine. The immune response can considerably reduce the risk of developing invasive meningococcal disease.

Pharmacokinetics

Meningococcal vaccines are administered intramuscularly or subcutaneously, where they are absorbed into the systemic circulation. The onset of immunity typically occurs within 2-3 weeks after vaccination, and the duration of protection varies depending on the specific vaccine used. Most vaccines require booster doses to maintain immunity over time.

Contra-indications

• Severe allergic reaction to any component of the vaccine
• History of severe allergic reaction (e.g., anaphylaxis) after a previous dose

Adverse effects

• Fever
• Headache
• Fatigue
• Muscle pain
• Joint pain
• Nausea
• Rash
• Local reactions at the injection site (pain, redness, swelling)

Interactions

• Immunosuppressive therapies may reduce vaccine efficacy
• Concurrent administration with other vaccines is generally acceptable, but consult specific guidelines

Precautions

• Consider in patients with a history of Guillain-Barré syndrome
• Use with caution in individuals with moderate or severe acute illness
• Evaluate the risk of meningococcal disease in populations at increased risk

Pregnancy

The vaccine is recommended during pregnancy if there is a risk of exposure to meningococcal disease.

Breast-feeding

The vaccine is considered safe during breastfeeding.

Storage

Store in a refrigerator (2°C to 8°C). Do not freeze. Protect from light.

Formulations

• Meningococcal conjugate vaccine (MenACWY)
• Meningococcal B vaccine (MenB)
• Meningococcal polysaccharide vaccine

Mechanism of action

Polysaccharides exert their effects through various mechanisms, often involving the modulation of immune responses. For example, certain polysaccharides can act as pathogen-associated molecular patterns (PAMPs) that are recognized by pattern recognition receptors on immune cells, leading to the activation of innate immunity. Additionally, some polysaccharides can enhance the proliferation and activation of lymphocytes, such as T-cells and B-cells, thereby influencing adaptive immune responses. Some polysaccharides also play a role in anticoagulation by inhibiting thrombin and other factors in the coagulation cascade.

Pharmacodynamics

The pharmacodynamics of polysaccharides vary widely depending on their structure and the specific biological pathways they influence. For instance, polysaccharides that act as immunomodulators can increase cytokine production, enhance phagocytosis by macrophages, and promote the differentiation of immune cells, leading to a more robust immune response. Furthermore, polysaccharides can exhibit anti-inflammatory properties by modulating the release of pro-inflammatory cytokines and chemokines. In the case of anticoagulant polysaccharides, their action may involve the binding and inhibition of specific clotting factors, thus preventing thrombus formation.

Pharmacokinetics

The pharmacokinetics of polysaccharides depend on their molecular weight, structure, and route of administration. Generally, polysaccharides are poorly absorbed in the gastrointestinal tract when taken orally due to their large size and complexity. However, certain polysaccharides are designed for parenteral administration, where they can be directly introduced into the bloodstream. Following administration, they may be metabolized by specific enzymes or by gut microbiota. The elimination half-life can vary significantly, influenced by factors such as the degree of sulfation or acetylation, which can affect their

Pregnancy

Polysaccharides are generally considered safe during pregnancy, but specific formulations should be evaluated on a case-by-case basis. Always consult a healthcare provider.

Breast-feeding

Polysaccharides are typically considered safe during breastfeeding, although individual formulations may vary. Consultation with a healthcare provider is recommended.

Storage

Polysaccharides should be stored in a cool, dry place, away from direct sunlight and moisture. Specific storage conditions may vary depending on the formulation.

Indications

• Diphtheria prophylaxis
• Tetanus prophylaxis
• Pertussis prophylaxis (when combined with other vaccines)

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations for pediatric immunization with toxoids.

Adults: Refer to specific guidelines for each toxoid vaccine, as dosing may vary based on the type of vaccine and individual patient factors.

Mechanism of action

Toxoids work by stimulating the immune system to produce antibodies against the toxin without causing disease. When administered, the immune system recognizes the toxoid as a foreign substance and generates a specific immune response. This includes the production of immunoglobulin G (IgG) antibodies that can neutralize the active toxin if the individual is exposed to the bacteria in the future.

Pharmacodynamics

The pharmacodynamics of toxoids involve the activation of the adaptive immune response. After vaccination, dendritic cells present the antigen to T cells, which then help B cells differentiate into plasma cells that produce specific antibodies. The presence of these antibodies provides immunity against the toxin by neutralizing its effects, thereby preventing the disease associated with the original bacterial toxin.

Pharmacokinetics

Toxoids are typically administered via intramuscular or subcutaneous injection. Following administration, they are gradually taken up by antigen-presenting cells, which then process and present the toxoid to T cells. The immunogenic response can develop over several weeks. The duration of immunity can vary, necessitating booster doses to maintain adequate antibody levels over time.

Adverse effects

• Local reactions at the injection site, such as pain, swelling, or redness.
• Fever.
• Fatigue.
• Headache.
• Allergic reactions in rare cases.

Precautions

• Use with caution in individuals with a history of severe allergic reactions to a vaccine component.
• Monitor patients for allergic reactions post-vaccination.

Pregnancy

Toxoids are generally considered safe during pregnancy; however, consultation with a healthcare provider is recommended.

Breast-feeding

Toxoids are considered safe for use during breastfeeding.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Diphtheria toxoid
• Tetanus toxoid
• Pertussis toxoid